Alios BioPharma Lands $41M In Series B
South San Francisco-based Alios BioPharma said Monday that it has raised $41M in a Series B funding round. The funding came from Novo Ventures, SR One, Roche Venture Fund, and Novartis Ventures. A new, undisclosed investor led the round. Alios BioPharma is led by Lawrence M. Blatt, Ph.D. The company is developing antiviral drugs, initially aimed at influenza and Rhinovirus.
posted on Tuesday, April 8, 2014
Related companies:
Alios Biopharma
Related stories:
> Alios Biopharma Raises $32M
> Alios BioPharma Gains $8.4M
> Limerick BioPharma Gains $15M
> SutroVax Finds $22M
> Principia Biopharma Raises $50M
silicontap.com Home